“Normal” Insulin Secretion: The Goal of Artificial Insulin Delivery Systems?

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Diabetes Care

• Publication date

  1980-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.3.2.270PMID 6993139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• KINETIC ANALYSIS OF INSULIN BEHAVIOR BY INTERACTIVE SIMULATION

  1979cited by this paper
• C-peptide Metabolism and the Liver

  1978cited by this paper
• The Controversy Concerning Counterregulatory Hormone Secretion: A Hypothesis for the Prevention of Diabetic Ketoacidosis?

  1977cited by this paper
• Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

  1975cited by this paper
• Plasma insulin and glucose profiles in normal, obese, and diabetic persons.

  1973cited by this paper
• Insulin Concentrations in Portal Venous and Peripheral Venous Blood in Man Following Administration of Glucose, Galactose, Xylitol and Tolbutamide*

  1973cited by this paper
• Extraction of insulin by liver.

  1973cited by this paper
• Portal and Peripheral Vein Immunoreactive Insulin Concentrations Before and After Glucose Infusion

  1970cited by this paper
• Clearance of Porcine Insulin, Proinsulin, and Connecting Peptide by the Isolated Rat Liver 1

  1970cited by this paper
• Regulation of insulin secretion by the intestinal hormone, secretin: studies in man via transumbilical portal vein catheterization.

  1968cited by this paper
• Studies of the metabolism and distribution of albumin with autologous I131-albumin in healthy men.

  1963cited by this paper
• Determination of the hepatic arterial blood flow and oxygen supply in man by clamping the hepatic artery during surgery.

  1962cited by this paper
• Direct Measurement of Hepatic Blood Flow in Surgical Patients: With Related Observations on Hepatic Flow Dynamics in Experimental Animals

  1962cited by this paper
• Studies on tissue uptake of insulin in man using a differential immunoassay for endogenous and exogenous insulin.

  1961cited by this paper

• Anionic Lipid Catalyzes the Generation of Cytotoxic Insulin Oligomers

  2025influential citation
• Dermal and transdermal peptide delivery using enhancer molecules and colloidal carrier systems. Part V: Transdermal administration of insulin.

  2022cites this paper
• USABILITY AND PATIENT ACCEPTANCE OF PREFILLED OR REUSABLE INSULIN PENS

  2021cites this paper
• Artificial Pancreas Control Strategies Used for Type 1 Diabetes Control and Treatment: A Comprehensive Analysis

  2020cites this paper
• Fluid Nanocarrier for Insulin for Noninvasive Treatment of Diabetes Mellitus

  2020cites this paper
• Pediatric Diabetes: Review Article

  2019cites this paper
• Insulin Resistance and Atherosclerosis: Implications for Insulin Sensitizing Agents.

  2019cites this paper
• Quantitative path to deep phenotyping: Possible importance of reduced hepatic insulin degradation to type 2 diabetes mellitus pathogenesis

  2018cites this paper
• Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment

  2017cites this paper
• Reduced peripheral activity leading to hepato‐preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes

  2016cites this paper
• NovoPen Echo® insulin delivery device

  2016cites this paper
• Celebrating 30 years…

  2014cites this paper
• Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects

  2014cites this paper
• Lipoprotein metabolism in patients with type 1 diabetes under intensive insulin treatment

  2013cites this paper
• Insulin Self-injection in School by Children with Type 1 Diabetes Mellitus

  2012cites this paper
• A review of modern insulin analogue pharmacokinetic and pharmacodynamic profiles in type 2 diabetes: improvements and limitations

  2011cites this paper
• Diabetes correction in pancreatectomized canines by orally absorbable insulin-deoxycholate complex.

  2010cites this paper
• Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation

  2010cites this paper
• Free insulin profiles in insulin-dependent diabetics treated with one or two insulin injections per day.

  2009cites this paper
• The effect of Lantus on glycemic control in children and adolescents with type 1 diabetes mellitus

  2007cites this paper
• Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes.

  2006cites this paper
• Insulin: a model system for nanomedicine?

  2006cites this paper
• Novel pharmacologic agents for type 2 diabetes.

  2005cites this paper
• A new drug carrier, Nα-deoxycholyl-l-lysyl-methylester, for enhancing insulin absorption in the intestine

  2005cites this paper
• Therapy with insulin glargine (Lantus) in toddlers, children and adolescents with type 1 diabetes.

  2005cites this paper
• Closed-loop insulin delivery-the path to physiological glucose control.

  2004cites this paper
• Randomized cross-over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens.

  2003cites this paper
• Oral Insulin Product Hexyl-Insulin Monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: The Glucose Stabilization Effects of HIM2

  2002cites this paper
• Insulin self-association and the relationship to pharmacokinetics and pharmacodynamics.

  2001cites this paper
• Pharmacokinetics and pharmacodynamics of insulin aspart, a rapid-acting analog of human insulin, in healthy Japanese volunteers.

  2000cites this paper
• Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart

  2000cites this paper
• Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers

  1999cites this paper
• Insulin Management of Insulin-Dependent Diabetes Mellitus

  1999cites this paper
• The long acting human insulin analog HOE 901: characteristics of insulin signalling in comparison to Asp(B10) and regular insulin.

  1998cites this paper
• The Long Acting Human Insulin Analog HOE 901: Characteristics of Insulin Signalling in Comparison to Asp(B10) and Regular Insulin

  1998cites this paper
• Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group.

  1997cites this paper
• A study of the factors which may influence the isolation of porcine islets of Langerhans

  1997cites this paper
• Platypus insulin : structural analysis, chemical synthesis and physico-chemical properties

  1996cites this paper
• Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen

  1995cites this paper
• Intensified insulin therapy.

  1993cites this paper
• Recombinant-DNA-derived insulin analogues as potentially useful therapeutic agents.

  1993cites this paper
• Effects of the Anatomical Region Used for Insulin Injections on Glycemia in Type I Diabetes Subjects

  1993cites this paper
• Relationship Between Absorption of Radiolabeled Soluble Insulin, Subcutaneous Blood Flow, and Anthropometry

  1992cites this paper
• Intranasal Insulin

  1992cites this paper
• Insulin therapy in insulin-dependent (type I) diabetes mellitus.

  1992cites this paper
• Insulin analogues with improved absorption characteristics.

  1992cites this paper
• Intranasal Administration of Insulin With Phospholipid as Absorption Enhancer: Pharmacokinetics in Normal Subjects

  1992cites this paper
• Therapie des Typ-I-Diabetes

  1992cites this paper
• Conventional and Sprinkler Needle Injection of Magnesium Insulin

  1992cites this paper
• Absorption Kinetics and Action Profiles of Subcutaneously Administered Insulin Analogues (AspB9GluB27, AspB10, AspB28) in Healthy Subjects

  1991cites this paper
• Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells

  1991cites this paper
• Comparison of Subcutaneous Soluble Human Insulin and Insulin Analogues (AspB9, GluB27; AspB10; AspB28) on Meal-Related Plasma Glucose Excursions in Type I Diabetic Subjects

  1991cites this paper
• [Insulin analogs in 1991].

  1991cites this paper
• Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes.

  1990cites this paper
• Monomeric Insulins and Their Experimental and Clinical Implications

  1990cites this paper
• NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.

  1989cites this paper
• Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.

  1988cites this paper
• Behandlung des Diabetes

  1985cites this paper
• The Relationship between Plasma Concentration and Disappearance Rate of Immunoreactive Insulin in the Conscious Dog

  1985cites this paper
• Diabetic retinopathy: a review of general medical factors in patient care.

  1984cites this paper
• Stabilisation of dissolved proteins against denaturation at hydrophobie interfaces

  1984cites this paper
• Importance of early postprandial insulin delivery in insulin-dependent diabetics

  1984cites this paper
• Treatment of diabetes with insulin. From art to science.

  1983cites this paper
• Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

  1983cites this paper
• Behandlung des Diabetes

  1982cites this paper
• C-Peptide

  1982cites this paper
• Insulin Receptor Binding to Fat and Blood Cells and Insulin Action in Fat Cells from Insulin-dependent Diabetics

  1982cites this paper
• Patient self-monitoring of blood glucose and refinements of conventional insulin treatment.

  1981cites this paper
• [Substitutes for the endocrine pancreas].

  1981cites this paper
• Treatment of diabetes mellitus by devices.

  1981cites this paper
• Some Engineering Aspects of Insulin Delivery Systems

  1980cites this paper
• International Journal of Nanomedicine Dovepress Hydrophobic Ion Pairing of an Insulin-sodium Deoxycholate Complex for Oral Delivery of Insulin

  year unknowncites this paper